I have data on NanoString for samples with two different phenotypes based on gene expression profiling and GSEA: 'high' and 'low'.
A priori we categorised cases as high or low and now tested NanoString on a 53 gene signature for 6 cases (3 previously identified as 'low', 3 previously identified as 'high'; these were tested in duplicate).
I need advice about how I can no analyse the data. We have run normalisations (there are some issues with this) but I cannot work out how to best assess significance and fold change.
Any advice gratefully received.
A priori we categorised cases as high or low and now tested NanoString on a 53 gene signature for 6 cases (3 previously identified as 'low', 3 previously identified as 'high'; these were tested in duplicate).
I need advice about how I can no analyse the data. We have run normalisations (there are some issues with this) but I cannot work out how to best assess significance and fold change.
Any advice gratefully received.
Comment